Central sleep apnea (CSA) is due to temporary failure in the pontomedullary inspiratory
pacemaker generating breathing rhythm. Consequently, there is no medullary inspiratory …

We developed a short-length document that clearly delineates a prudent approach to and
criteria for reimbursement of positive airway pressure (PAP) costs for the treatment of …

This issue of AJRCCM (pp. 773–780) features a randomized controlled trial (RCT)(1) to add
to the growing database of continuous positive airway pressure (CPAP) treatment for …

The minimal disease severity at which patients with the sleep apnea/hypopnea syndrome
(SAHS) gain benefit from treatment is not well characterized, although a pilot study of …

The use of continuous positive airway pressure (CPAP) in treating symptoms associated
with OSAHS is reviewed. Although it is an imperfect intervention, it continues to evolve and …

Positive airway pressure (PAP) is used to treat obstructive sleep apnea (OSA), central sleep
apnea (CSA), and chronic hypoventilation. This document provides a systematic analysis …

A common clinical dilemma faced by sleep physicians is in deciding the level of severity at
which patients with obstructive sleep apnea (OSA) should be treated. There is particular …

Abstract Purpose of Review The purpose of this review is to discuss the pathogenesis,
clinical manifestations, diagnosis, and treatment, including areas of controversy and …

Continuous positive airway pressure (CPAP) has become the treatment of choice for
obstructive sleep apnea syndrome. Successful therapy with CPAP depends greatly on …

Central sleep apnea (CSA) and its variant Hunter-Cheyne-Stokes breathing (HCSB) result
when respiratory rhythmogenesis temporarily fails to initiate inspiration or, in the case of …